List of Figures
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 15
Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials, G7 Countries (%), 2018* 16
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials, E7 Countries (%), 2018* 21
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 31
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36
GlobalData Methodology 96


List of Tables
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials, G7 Countries (%), 2018* 17
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials, E7 Countries (%), 2018* 22
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Phase, 2018* 25
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 31
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 37